Abstract / Description of output
There is a pressing need for new biomarkers that can improve the care of patients with paracetamol poisoning, a common clinical problem. In this issue of Clinical Toxicology a new marker is proposed that has a number of attractive properties. This commentary discusses the use of biomarkers in the context of the management of paracetamol-induced liver injury. New biomarkers should allow better triage and management of & "at risk" patients.
| Original language | English |
|---|---|
| Pages (from-to) | 785-6 |
| Number of pages | 2 |
| Journal | Clinical Toxicology |
| Volume | 48 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - Oct 2010 |
Keywords / Materials (for Non-textual outputs)
- Acetaminophen
- Alanine Transaminase
- Analgesics, Non-Narcotic
- Biomarkers
- Drug-Induced Liver Injury
- Humans